Withholding Antibiotic Treatment in Pneumonia Patients With Dementia

A Quantitative Observational Study

Author Information
<http://archinte.ama-assn.org/issues/v162n15/rfull/#aainfo>   Jenny T. van
der Steen, MSc; Marcel E. Ooms, MD, PhD; Herman J. Adèr, PhD; Miel W. Ribbe,
MD, PhD; Gerrit van der Wal, MD, PhD
Background  Pneumonia is a life-threatening disease in nursing home patients
with dementia. Physicians and families face choices about whether to
withhold antibiotics when patients are expected to die soon or when
treatment may be burdensome. However, little information exists on what
factors influence this complex decision-making process.
Objective  To identify factors associated with decisions on whether to
withhold curative antibiotic treatment in patients with dementia who have
pneumonia.
Methods  We performed an observational cohort study with 3-month monitoring
for cure and death. Patients with pneumonia (N = 706) were enrolled in
nursing home units for patients with dementia from all over the Netherlands
(61 nursing homes). Characteristics of patients, physicians, and facilities
were related to the outcome of withholding antibiotic treatment.
Results  In 23% of the patients, antibiotic treatment was withheld. The
other patients received antibiotics with palliative (8%) or curative (69%)
intent. Compared with the patients who received antibiotics with curative
intent, patients in whom antibiotic treatment was withheld had more severe
dementia, had more severe pneumonia, had lower food and fluid intake, and
were more often dehydrated. In addition, withholding antibiotics occurred
more often in the summer and in patients with an initial episode of
pneumonia. Characteristics of facilities and physicians were unrelated to
the decision. However, considerable variation occurred in how patient age,
aspiration, and history of pneumonia were related to decision making by
individual physicians.
Conclusions  In the Netherlands, antibiotic treatment is commonly withheld
in pneumonia patients with severe dementia who are especially frail.
Understanding the circumstances in which this occurs can illuminate the
international discussion of appropriate dementia care.
Arch Intern Med. 2002;162:1753-1760
IOI10658
PNEUMONIA OCCURS frequently in nursing home patients. 1
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r1>  It is a potentially
life-threatening infectious disease, 1-3
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r1>  especially in
patients with end-stage dementia. 4
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r4>  From studies in US
nursing homes, it seems that most pneumonias are treated with antibiotics.
5-7 <http://archinte.ama-assn.org/issues/v162n15/rfull/#r5>  Residents with
pneumonia are also often admitted to the hospital. 1
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r1> , 8-11
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r8>  However, patients
with dementia are frequently excluded from studies. 12
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r12>  In fact, as early
as 1979, withholding curative treatment was observed in US nursing homes by
Brown and Thompson. 13
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r13>  Their classic
study on nontreatment in 9 extended care facilities in Seattle, Wash, showed
that 41% of respiratory infections were (intentionally) not treated with
antibiotics and/or patients were not hospitalized.
Moreover, during the last decade, questions have been increasingly raised on
treatment decisions for patients with advanced dementia. 4
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r4> , 12
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r12> , 14
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r14> , 15
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r15>  In a study on
hospitalized patients, Morrison and Siu 4
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r4>  observed that
pneumonia was not considered a terminal diagnosis in patients with end-stage
dementia, despite the high probability of death. They questioned whether
these patients should have received as many burdensome procedures as
cognitively intact persons.
With progressive dementia, patients also become incompetent to make
decisions. 16-18 <http://archinte.ama-assn.org/issues/v162n15/rfull/#r16>
They become unable to balance the benefits and burdens of treatments
themselves. Physicians and families may consider curative treatment too
burdensome and benefits too small if life expectancy is short and aggressive
procedures would be required; therefore, they decide to withhold treatment.
12 <http://archinte.ama-assn.org/issues/v162n15/rfull/#r12> , 19
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r19>  Attempting cure
may cause a burden when, for example, intravenous hydration or antibiotics
require restraints to prevent removal of the intravenous line. 4
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r4> , 20
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r20>  In addition, the
potential benefit of treatment is decreased in patients with dementia
considering their diminished expected life span, altering the risk-benefit
ratio. 12 <http://archinte.ama-assn.org/issues/v162n15/rfull/#r12>  Some
even raise the question if further exposure to the deteriorating course of
the dementia process represents an undue burden of pneumonia treatment. 16
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r16>  In considering
benefits and burdens of the treatment options, open discussions with family
members are highly desirable for all parties involved. 21
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r21>
Little is known about which factors influence decisions about whether to
withhold antibiotic treatment in incompetent patients. Even less is known on
variation among physicians with respect to these considerations. Until now,
studies have relied on reporting of physicians' opinions in discussions on
life-sustaining treatment 22
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r22> , 23
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r23>  or on hypothetical
cases (vignettes). 24
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r24> , 25
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r25>
In the Netherlands, as in Great Britain, 26
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r26>  physicians are
culturally and legally responsible for the ultimate decision about
withholding treatment in incompetent patients. Good practice, however,
involves consultation with families to reconstruct patients' wishes if their
present wish is unknown or to discuss what is in the patients' best interest
if no wish could be reconstructed. 17
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r17> , 27
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r27>
In this article, we examine factors associated with the decision to withhold
antibiotic treatment in nursing home patients with pneumonia and severe
dementia and the variation among physicians regarding this decision.
Characteristics of nursing home patients with dementia, their treating
physicians, and the facilities are reviewed to look at sources of variation
in withholding antibiotic treatment. Our data provide insight into the
factors that influence decision making and should facilitate the
international debate among physicians on this controversial issue.



PATIENTS AND METHODS



Between October 1, 1996, and July 31, 1998, we identified 706 consecutive
pneumonia patients in psychogeriatric units of Dutch nursing homes in the
Pneumonia Study. Dutch nursing homes are divided into somatic (physical
disability) and psychogeriatric units. Most (96%) of the patients in the
latter units have dementia and stay within the unit the rest of their lives.
Physicians undergo a 2-year training program following their basic clinical
training to become certified as a nursing home physician. These physicians
belong to the staff of the nursing homes. Facilities employ physicians in a
ratio of 1 full-time physician to 100 patients. 28-31
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r28>  Even after hours
or on weekends, ill residents are seen at the bedside; telephone consulting
is not usual practice in the Netherlands.
The Pneumonia Study was performed in 61 facilities all over the Netherlands
affiliated with our department and covered 24% of all long-term
psychogeriatric (dementia) care beds in the country. 30
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r30>  Nursing home
physicians in training (similar to a residency in the United States) at
these facilities participated in the study in 2 ways: by reporting on their
own patients and by monitoring form completion on all enrolled patients in
the facility. The treating physician (whether regular staff or a trainee)
was responsible for completing all data forms. Because facilities had agreed
to participate, the physicians' effort was considered part of their
employment. The physicians were informed of the 2 main study goals:
guideline development and assessing clinical predictors for the course of
pneumonia.
The patients had to meet the following criteria: (1) have a psychogeriatric
disease (almost always dementia); (2) reside in the nursing home for at
least 4 weeks; and (3) be diagnosed as having pneumonia by the physician.
The physicians were explicitly instructed to include terminal patients as
well. A patient could be included only once, even if a second episode of
pneumonia occurred during the study period.
The study protocol was approved by the medical ethics committee of the VU
University Medical Center. Confidentiality of data was guaranteed by
physicians providing coded information to the researchers (as opposed to
patient or physician names). Informed consent was not deemed necessary by
the ethics review committee because physicians were simply reporting
information gleaned from usual practice. However, patients and families were
informed of the study and were provided the opportunity to refuse transfer
of data to the researchers.
DATA COLLECTION

Patients were assigned to treatment solely on the basis of the decision of
the physician. Each patient was followed up for 3 months, during which
incident cure (recovery as judged by the treating physician) and death were
monitored continuously. The physicians completed questionnaires about the
patients at the time of the treatment decision that described the patient's
current condition (baseline) and their condition 2 weeks earlier (variables
recorded are displayed in Table 1
<http://archinte.ama-assn.org/issues/v162n15/fig_tab/ioi10658_t1.html>  and
Table 2
<http://archinte.ama-assn.org/issues/v162n15/fig_tab/ioi10658_t2.html> ).
Rehydration therapy was assessed 3 days after the treatment decision.
Demographic data on the physicians and the facility characteristics were
obtained during site visits by one of the authors (J.T.v.d.S.). During a
limited period (from March 1, 1997, until the end of data collection), data
on expected outcomes, advanced care planning, food intake, weight loss, and
vaccination for influenza were collected.
We used scales specifically developed for patients with severe dementia.
Discomfort was measured at baseline (also retrospectively) using the 9-item
observational Discomfort Scale–Dementia of Alzheimer Type, 32
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r32>  which ranges from
0 (no observed discomfort) to 27 (high level of observed discomfort). The
physicians were instructed on the proper use of the scale during a training
session in which an instructional videotape was shown. Several studies 32-36
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r32>  have demonstrated
acceptable reliability and validity. A small study indicated acceptable
reliability of retrospectively assessed data (J.T.v.d.S., H.J.A., J. van
Assendelft, MD, M. Kooistra, MD, P. Passier, MD, and M.E.O, unpublished
data, 1997). The severity of dementia before the onset of pneumonia was
measured at baseline, referring to the condition before the pneumonia, with
the Bedford Alzheimer Nursing Severity Scale (BANS-S). 37
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r37>  This scale
consists of assessments on seven 4-point items rating cognitive deficits,
functional deficits, and occurrence of pathologic symptoms, of which the
separate items are considered relevant with respect to decision making as
well. Summed scores range from 7 (no impairment) to 28 (complete
impairment). The BANS-S is a valid measure with discriminative power even in
patients with severe dementia, including those with dementias other than
Alzheimer disease. 38
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r38>  Subjective
clinical judgment on illness severity was rated on a numeric rating scale
running from 1 (not ill) to 9 (moribund). 39
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r39>
STATISTICAL ANALYSIS

The patients selected for analysis in this article included those in whom
antibiotic treatment was withheld (AB-withheld) and those in whom antibiotic
treatment was promptly initiated with the explicit goal of curing the
patient (AB-curative). Patients treated with antibiotics according to the
treating physician for palliative reasons (AB-palliative) are described
only. The chi2 statistic for contingency tables was used to test for
differences between AB-withheld and AB-curative patients in proportions of
symptom relief. Independent sample nonparametric tests were used to compare
time until death or recovery.
The relation of patient, physician, and facility variables with the
treatment decision was first examined with univariate logistic regression
analysis. Next, using forward stepwise logistic regression analysis, a
multivariable model for withholding antibiotic treatment was constructed.
Odds ratios (ORs) and 95% confidence intervals (CIs) were computed. All
facility, physician, and patient variables that were univariately related
were candidates for entry, except for the global measure on clinical
judgment of illness severity because it was not considered specific enough
to provide the desired information. Pneumonia symptoms were grouped to
assess relevance compared with other conditions. The variables collected
during a limited period were tested in the final model only to preserve
power. Accounting for the hierarchical structure of the data, in which
variables at the facility, physician, and patient level were present, we
used logistic multilevel analysis. 40
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r40> , 41
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r41>  This allows
assessment of the level of variation, that is, to test whether patient
variation, physician variation, or facility variation best explains the
results. The multilevel modeling was performed with respect to variation on
the physician level. Therefore, where the random contribution to a variable
could not be neglected, there was a lack of uniformity among physicians with
respect to that variable. This implies that physicians weighed such a
variable differently in their decisions. Model performance (calibration and
discrimination) 42 <http://archinte.ama-assn.org/issues/v162n15/rfull/#r42>
was tested using the Hosmer-Lemeshow goodness-of-fit statistic (C test) 43
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r43>  and the area under
the receiver operating characteristic curve (c statistic), respectively. 44
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r44>  Finally, to
examine which items of the summary measures in the model were most
important, the summary measures were replaced by their separate items. The
multilevel analysis was performed with the computer program MlwiN 45
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r45> ; all other
analyses were performed using SPSS statistical software for Windows, version
7.5, except for model performance, which was performed using version 9.0
(SPSS Inc, Chicago, Ill).



RESULTS



PATIENTS AND TREATMENTS

Treatment with antibiotics was withheld in 23% (AB-withheld) of the 706
patients in the Pneumonia Study. A few patients (8%) were treated with
antibiotics according to their physicians for palliative reasons (AB-palliat
ive), whereas all others (69%) were treated with antibiotics for curative
reasons (AB-curative).
Table 3
<http://archinte.ama-assn.org/issues/v162n15/fig_tab/ioi10658_t3.html>
describes the characteristics of the treatments used in the patients who
were treated promptly. Antibiotics were overwhelmingly given orally. In
AB-withheld patients, symptom relief in general and opiates specifically
were instituted more often than in AB-curative patients (P<.001). Only 0.6%
(n = 4) of all patients were admitted to a hospital at any time during the
disease course. In these patients, antibiotic treatment had been started in
the nursing home initially. Further analyses are restricted to the 165
AB-withheld patients and 470 AB-curative patients treated promptly. Most
patients had severe dementia ( Table 4
<http://archinte.ama-assn.org/issues/v162n15/fig_tab/ioi10658_t4.html> ),
with an average BANS-S score of 17.5. (For comparison, in a study of
Alzheimer patients, an average BANS-S score of 17.1 has been associated with
an average Mini-Mental State Examination 46
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r46>  score of 5.0. 38
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r38> )
PHYSICIANS' EXPECTATIONS

At the time of the treatment decision, the physicians expected 96% of
AB-withheld patients (55/57) to die within "a short or a somewhat longer
time" when withholding antibiotics (the sample size is smaller because we
asked this question for only a limited portion of the study). However, in
37% (n = 21) of these cases, physicians believed that the patients would
have been cured (28% [n = 16] partly and 9% [n = 5] fully) if they had been
treated with antibiotics. The physicians expected that 98% (136/139) of the
AB-curative patients would be at least partly cured within 1 month.
FACTORS THAT INFLUENCE DECISION MAKING

Most of the more than 50 patient factors tested proved to be univariately
significantly related to withholding antibiotic treatment ( Table 1
<http://archinte.ama-assn.org/issues/v162n15/fig_tab/ioi10658_t1.html>  and
Table 2
<http://archinte.ama-assn.org/issues/v162n15/fig_tab/ioi10658_t2.html> ).
The strongest association in univariate analysis was with the clinical
judgment of illness severity at the time of the treatment decision (OR, 2.7
per point increase on a 9-point scale; 95% CI, 1.8-3.9). The illness
severity of AB-withheld patients could be characterized as severe (mean
value, 7.1), and AB-curative patients were moderately to severely ill (mean
value, 5.4). Furthermore, strong associations were found with dehydration
(OR, 5.6; 95% CI, 3.9-8.3), the illness severity 2 weeks before the
treatment decision (OR, 1.9 per point increase on the 9-point scale; 95% CI,
1.6-2.1), and eating dependency at the time of the treatment decision (OR,
5.4; 95% CI, 3.3-9.0).
Because unexpectedly in the youngest quartile of patients (<80 years)
antibiotic treatment was more often withheld, age was tested for its
relation with a variety of possible relevant variables. The younger
pneumonia patients actually had higher scores of discomfort at the time of
the treatment decision, had more severe dementia, and were more severely ill
at the time of and before the treatment decision. Nevertheless, for these
patients the illness severity was less predictive of withholding antibiotic
treatment (OR, 1.9; 95% CI, 1.4-2.4) than for older patients (OR, 3.3; 95%
CI, 2.5-4.3). Of the physician and facility characteristics, the only
significant characteristic was the number of psychogeriatric beds in the
facility: a small number was predictive of withholding antibiotic treatment
more frequently (OR, 1.2 per 50 beds less; 95% CI, 1.1-1.4).
FACTORS THAT INFLUENCE DECISION MAKING INDEPENDENTLY

Illness severity by clinical judgment seemed to be the strongest independent
predictor of withholding antibiotic treatment. Table 5
<http://archinte.ama-assn.org/issues/v162n15/fig_tab/ioi10658_t5.html>
gives a more specified model, which did not include illness severity, and
shows that the most important independent predictors of withholding
antibiotic treatment were all patient factors. Severe dementia was the
strongest predictor in this model. Other independently significant
predictors were number of symptoms of pneumonia, insufficient drinking,
dehydration, treatment in the summer, aspiration, and previous pneumonia.
The most significant item of the BANS-S for severity of dementia with
respect to withholding antibiotic treatment proved to be eating dependency 2
weeks before the treatment decision. Likewise, of pneumonia symptoms,
decreased alertness was more important than Cheyne-Stokes respiration,
tachypnea, coughing, respiratory distress, fever, malaise, and abnormal
chest auscultation.
Advanced care planning (results used in decision making in 59% of cases), if
included in the final model of Table 5
<http://archinte.ama-assn.org/issues/v162n15/fig_tab/ioi10658_t5.html>
(data not shown), was also an important independent predictor (OR, 3.3; 95%
CI, 1.4-7.4; n = 243). It hardly affected the ORs of the other variables in
the model. In addition, there were no significant differences in the
characteristics of the model between patients for whom advanced care
planning had taken place and for whom this had not taken place (total group,
AB-curative, or AB-withheld).
VARIATION IN CONSIDERING PATIENT CHARACTERISTICS

Facilities varied negligibly in withholding antibiotic treatment (variation
on nursing home level in multilevel analyses). However, variation with
respect to withholding antibiotic treatment at the physician level was about
5 times larger than at the patient level. This was owing to variation in
importance for withholding antibiotic treatment attributed to certain
patient characteristics. Namely, the best fitting model allowed random
variation for 3 of the 8 factors in the model of Table 5
<http://archinte.ama-assn.org/issues/v162n15/fig_tab/ioi10658_t5.html>
(age, aspiration, and having previously had pneumonia). This indicated that
for these factors, the OR varied among physicians. The individual physicians
seemed to vary in the degree to which these predictors were considered when
deciding to withhold treatment. Thus, the physicians varied more in their
treatment of patients younger than 80 years as opposed to older patients, in
patients who previously had pneumonia as opposed to not having prior
pneumonia, and in patients who were thought to have aspirated compared with
patients for whom this was not thought to be the cause of pneumonia.
The values of the other 5 predictors in the multilevel model of Table 5
<http://archinte.ama-assn.org/issues/v162n15/fig_tab/ioi10658_t5.html>
seemed almost equally important among individual physicians when deciding to
withhold antibiotic treatment. Modeling only these 5 predictors (dementia
severity, number of pneumonia symptoms, insufficient drinking, dehydration,
and treatment in the summer) showed that model discrimination was as good as
discrimination of the complete model, including the variables that showed
random variation (area under receiver operating characteristic curve, 0.85
compared with 0.86 for the complete model), as could be expected.
DISEASE COURSE

Most of the AB-withheld patients (90%) died within 1 month, as did 48% of
the AB-palliative patients. Of the AB-curative patients, 27% died within 1
month. Moreover, most of the AB-withheld patients who died during the
3-month follow-up period died within a few days (median, 2 days), which was
considerably earlier than the AB-curative patients who died despite
antibiotic treatment (median, 11.5 days; all P<.001 in this section). Median
time until death of AB-palliative patients was 5.5 days. Twelve AB-withheld
patients survived. The time for their recovery (median, 9.5 days) was not
significantly different from the recovery time of the AB-curative patients
(median, 10 days). Median recovery time for AB-palliative patients was 9
days.



COMMENT



Most patients with dementia in Dutch nursing homes who develop pneumonia are
treated with antibiotics, typically given orally. Nevertheless, in 23% of
patients, antibiotic treatment is withheld. Physicians think antibiotics
could have saved the lives of 37% of these patients. Almost two thirds were
expected to have died even if treated with antibiotics. Characteristics of
facilities, such as religious affiliation, and physician characteristics
were not associated in multilevel analysis with the treatment chosen and
thus did not seem to substantially influence the decision making. Several
patient characteristics entered as fixed effects at the physician level in
the multilevel model and thus seem to be uniformly considered by physicians
in decision making. However, 3 variables entered as random effects at the
physician level, which suggests substantial variation among physicians in
how these patient characteristics are considered in decision making.
The typical patient with dementia in whom antibiotic treatment is withheld
is severely ill. Patients have severe dementia, have severe pneumonia (many
symptoms), have low intake of food and fluids, and are often dehydrated. In
addition, withholding antibiotics occurs more often in the summer. These
characteristics alone are highly predictive of withholding treatment
(apparent from excellent model fit), and they are considered in the same
way. However, variation occurs on the importance placed on not having had
pneumonia previously, aspiration, and a relatively young age. Most
physicians and families were inclined to treat with antibiotics those
patients who had survived pneumonia before and for most of whom (96%) an
active approach had been used. In contrast, others seemed to consider
recurrent pneumonia one of the reasons to withhold antibiotic treatment.
Similarly, some physicians (and families) tended to withhold treatment in
patients who aspirated or were relatively young, whereas others did not.
Management of pneumonia in advanced dementia may exhibit considerable
variation in treatment internationally. Our findings suggest that Dutch
physicians tend to uniformly withhold antibiotics in some patients but vary
in the weight they place on other factors. Variation might be expected to be
even greater in countries such as the United States where there is much less
ethical or legal clarity about when to initiate a strictly palliative
hospice approach for dementia. Our findings illuminate the international
discussion on this topic by showing which patients do not receive antibiotic
treatment in a setting where such practices are common.
Severity of dementia (or deterioration) has been associated with withholding
antibiotic treatment independently in both the current study and other
observational studies. 13
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r13> , 47
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r47>  In our study,
patients in whom antibiotics were withheld had an average BANS-S severity of
dementia score of 20.4. A study 37
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r37>  of the BANS-S
suggests that more than 90% of these patients would have a score of 0 on the
Mini-Mental State Examination.
Antibiotic treatment was also often withheld in patients with dehydration
and insufficient drinking. Antibiotic treatment may have been expected to be
less effective or to cause drug-related toxic effects. 48
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r48>  Furthermore, the
(in)dependent intake of food and fluids may have a subjective (symbolic)
meaning as well, because effects were independent. Considerations other than
medical may also have played a role in withholding antibiotic treatment in
relatively young patients in whom, though more ill, the general illness
severity was less predictive. This was most evident for the 37% of patients
who were not treated with antibiotics but whom physicians thought could have
been cured. For three quarters of these patients, the expectation was for
only partial cure. We did not specify this, but the physicians may have
feared these patients would be cured of the pneumonia at the cost of a
decreased general condition. The occurrence of a pneumonia may have been use
d as an opportunity to let the patient die a natural death. The pneumonia
may have been seen as "the old man's friend." 49
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r49>
Information from the literature concerning the frequency of withholding
antibiotics is limited. Earlier studies 13
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r13> , 47
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r47> , 50
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r50> , 51
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r51>  indicated that
antibiotics were withheld in a quarter to half of patients, but these
studies were not nationwide and included less severe infections than
pneumonia. One study 50
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r50>  concerned a
population with severe dementia that was similar to our study. Physicians in
this specific US nursing home and the Netherlands apparently consider
withholding antibiotic treatment in pneumonia patients with dementia as an
option. In frail patients and, more specifically, in patients with severe
dementia, the physicians may have been inclined to forgo the more technical
solutions often associated with full curative treatment (intravenous
antibiotics and simultaneous rehydration). 12
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r12>  A nonaggressive
strategy in our frail study population is also obvious from rare use of
hospital transfer and procedures, such as blood tests, x-ray examinations,
tube feeding, and rehydration.
On the other hand, when cure was a goal, this was not achieved in more than
a quarter of the patients treated with antibiotics. In our study, typically
oral amoxicillin was given. In most Dutch hospitals and nursing homes,
amoxicillin is the first drug choice in case of unknown pathogens, 52
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r52>  which is generally
sufficient since antibiotic resistance is still not a major problem in the
Netherlands. 53 <http://archinte.ama-assn.org/issues/v162n15/rfull/#r53>
Physicians were willing at times to start more invasive procedures in more
severely ill patients. Parenteral antibiotics (mostly intramuscular) were
used for more severely ill patients, although not for patients with more
severe dementia (analyses not shown). This finding suggests that withholding
antibiotic treatment was not merely because of, for example, problems with
oral intake. In our study, withholding antibiotic treatment was mostly, but
not always, accompanied by starting symptom relief. In patients treated with
antibiotics, treatment to relieve symptoms was started in only a few cases.
Apparently, the integrated approach, as suggested by Morrison and Siu, 54
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r54>  is not yet common
practice. Antibiotics were sometimes (8%) given for palliative reasons.
However, evidence of the palliative effects of antibiotics is lacking. 55
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r55>
A limitation of the present study is that we did not obtain direct
information from physicians, families, or medical records about the basis
for decisions that were made. Inferences about factors considered important
in the decision are based on variables that distinguish those patients who
did and did not receive antibiotics. However, lack of variation with respect
to a variable is indirect evidence that it is not weighted significantly in
decision making. Advanced care planning is common in many of the nursing
homes we studied, and good practice includes reconsulting with the family in
the acute situation, even if advanced care planning has taken place. 27
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r27>  On the other hand,
because the physicians did not know analyses on withholding treatment were
to be performed, it is also a strength of the design because they were not
pressured to exhibit socially desirable responses. Another limitation
concerns the diagnosis of pneumonia, which was often made without laboratory
or x-ray film confirmation. Besides a poor response to antibiotic treatment
(for example, in case of viral pneumonia), mistaken pneumonia diagnosis in
patients who in fact had chronic heart failure or pulmonary embolism may
have played a role in the patient population. However, in studying
physicians' decision making, their diagnosis is what is ultimately of
relevance. Finally, a strength of the study is limited patient variation;
patients being much the same makes it achievable to study decision making.
To our knowledge, this is the first large quantitative study in which
predictors of withholding antibiotic treatment in daily practice are
assessed. Our data may facilitate discussions on whether the identified
factors should really be important in the decision-making process and on
discrepancies between expected and actual outcomes. Furthermore, they raise
questions about how physicians should weigh patient factors in decision
making on withholding antibiotic treatment. Explicitly mentioning identified
factors during advanced care planning might be indicated.
We expect that there are some international differences in importance
attached to specific factors relating to treatment decisions. The factors we
identified relate predominantly to the dementia severity and the acute
illness. We suspect that similar factors would generally reflect current
physicians' attitudes in industrialized countries. They form a starting
point for the conceptualizing of guidelines. These predictors should be
examined prospectively for clinical 2
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r2> , 3
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r3>  but also for
ethical relevance in making decisions. Furthermore, to promote openness and
responsible decision making, it is helpful to have an ethical and legal
framework for decision making on whether to withhold antibiotic treatment.
17 <http://archinte.ama-assn.org/issues/v162n15/rfull/#r17> , 27
<http://archinte.ama-assn.org/issues/v162n15/rfull/#r27>  Having a practical
guideline including all these aspects is useful when discussing antibiotic
treatment options with the patient's family and also in advanced care
planning. This should promote prudent end-of-life care in frail, elderly
patients.



Author/Article Information


From the Institute for Research in Extramural Medicine (Ms van der Steen and
Drs Ooms, Adèr, Ribbe, and van der Wal), and the Departments of Nursing Home
Medicine (Drs Ooms and Ribbe), Clinical Epidemiology and Biostatistics (Dr
Adèr), and Social Medicine (Dr van der Wal), VU University Medical Center,
Amsterdam, the Netherlands.

Corresponding author: Jenny T. van der Steen, MSc, EMGO Institute, VU
University Medical Center, Amsterdam, Van der Boechorststraat 7, 1081 BT
Amsterdam, the Netherlands (e-mail: [log in to unmask]
<mailto:[log in to unmask]> ).
Accepted for publication February 6, 2002.
This study was supported by the Society Het Zonnehuis (Utrecht, the
Netherlands) and the Dutch Ministry of Health Care, Welfare and Sport (The
Hague, the Netherlands).
We thank the nursing home physicians of the 61 nursing homes involved in
this study and the members of the Advisory Committee of the Pneumonia Study:
J. Th. M. van Eijk, PhD, C. M. P. M. Hertogh, MD, PhD, G. J. Ligthart, MD,
PhD, M. T. Muller, PhD, and G. L. Schut, MD, PhD. Furthermore, we thank
Ellen M. Buunk-Kampers for her administrative support and F. Boersma, MD,
PhD, J. W. P. M. Konings, MD, PhD, and D. R. Mehr, MD, MS, for their
critical review of early versions of the manuscript.
Reprints not available from the authors.




REFERENCES



1. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr1>
Muder RR.
Pneumonia in residents of long-term care facilities: epidemiology, etiology,
management, and prevention.
Am J Med.
1998;105:319-330.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
9809694>
2. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr2>
Fine MJ, Smith MA, Carson CA, et al.
Prognosis and outcomes of patients with community-acquired pneumonia: a
meta-analysis.
JAMA.
1996;275:134-141.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
8531309>
3. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr3>
Medina-Walpole AM, Katz PR.
Nursing home-acquired pneumonia.
J Am Geriatr Soc.
1999;47:1005-1015.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
10443864>
4. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr4>
Morrison RS, Siu AL.
Survival in end-stage dementia following acute illness.
JAMA.
2000;284:47-52.
ABSTRACT <http://jama.ama-assn.org/issues/v284n1/abs/joc00756.html>   |
FULL TEXT <http://jama.ama-assn.org/issues/v284n1/rfull/joc00756.html>   |
PDF <http://jama.ama-assn.org/issues/v284n1/rpdf/joc00756.pdf>   |   MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
10872012>
5. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr5>
Fried TR, Gillick MR, Lipsitz LA.
Whether to transfer? factors associated with hospitalization and outcome of
elderly long-term care patients with pneumonia.
J Gen Intern Med.
1995;10:246-250.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
7616332>
6. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr6>
Mehr DR, Foxman B, Colombo P.
Risk factors for mortality from lower respiratory infections in nursing home
patients.
J Fam Pract.
1992;34:585-591.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
1578209>
7. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr7>
Marrie TJ, Durant H, Kwan C.
Nursing home-acquired pneumonia: a case-control study.
J Am Geriatr Soc.
1986;34:697-702.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
3489749>
8. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr8>
Jackson MM, Fierer J, Barrett-Connor E, et al.
Intensive surveillance for infections in a three-year study of nursing home
patients.
Am J Epidemiol.
1992;135:685-696.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
1580245>
9. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr9>
Beck-Sague C, Banerjee S, Jarvis WR.
Infectious diseases and mortality among US nursing home residents.
Am J Public Health.
1993;83:1739-1742.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
8259806>
10. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr10>
Mylotte JM, Naughton B, Saludades C, Maszarovics Z.
Validation and application of the pneumonia prognosis index to nursing home
residents with pneumonia.
J Am Geriatr Soc.
1998;46:1538-1544.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
9848815>
11. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr11>
Naughton BJ, Mylotte JM.
Treatment guideline for nursing home-acquired pneumonia based on community
practice.
J Am Geriatr Soc.
2000;48:82-88.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
10642027>
12. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr12>
Brauner DJ, Cameron Muir J, Sachs GA.
Treating nondementia illnesses in patients with dementia.
JAMA.
2000;283:3230-3235.
ABSTRACT <http://jama.ama-assn.org/issues/v283n24/abs/jsc90341.html>   |
FULL TEXT <http://jama.ama-assn.org/issues/v283n24/rfull/jsc90341.html>   |
PDF <http://jama.ama-assn.org/issues/v283n24/rpdf/jsc90341.pdf>   |
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
10866871>
13. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr13>
Brown NK, Thompson DJ.
Nontreatment of fever in extended-care facilities.
N Engl J Med.
1979;300:1246-1250.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
431683>
14. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr14>
Hurley AC, Volicer BJ, Volicer L.
Effect of fever-management strategy on the progression of dementia of the
Alzheimer type.
Alzheimer Dis Assoc Disord.
1996;10:5-10.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
8919491>
15. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr15>
Finucane TE, Christmas C, Travis K.
Tube feeding in patients with advanced dementia: a review of the evidence.
JAMA.
1999;282:1365-1370.
ABSTRACT <http://jama.ama-assn.org/issues/v282n14/abs/jsc90078.html>   |
FULL TEXT <http://jama.ama-assn.org/issues/v282n14/rfull/jsc90078.html>   |
PDF <http://jama.ama-assn.org/issues/v282n14/rpdf/jsc90078.pdf>   |
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
10527184>
16. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr16>
Hertogh CMPM, Ribbe MW.
Ethical aspects of medical decision-making in demented patients: a report
from the Netherlands.
Alzheimer Dis Assoc Disord.
1996;10:11-19.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
8919492>
17. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr17>
van der Steen JT, Muller MT, Ooms ME, van der Wal G, Ribbe MW.
Decisions to treat or not to treat pneumonia in demented psychogeriatric
nursing home patients: development of a guideline.
J Med Ethics.
2000;26:114-120.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
10786322>
18. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr18>
Karlawish JHT, Quill T, Meier DE, for the ACP-ASIM End-of-Life Care
Consensus Panel.
A consensus-based approach to providing palliative care to patients who lack
decision-making capacity.
Ann Intern Med.
1999;130:835-840.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
10366374>
19. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr19>
Beauchamp TL, Childress JF.
Principles of Biomedical Ethics.
4th ed. Oxford, England: Oxford University Press; 1994.
20. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr20>
Volicer L, Rheaume YL, Brown J, et al.
Ethical issues in the treatment of advanced Alzheimer dementia: hospice
approach.
In: Volicer L, Fabiszewski KJ, Rheaume YL, Lasch KE. Clinical Management of
Alzheimer's Disease. Rockville, Md: Aspen Publishers Inc; 1988:167-182.
21. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr21>
Hanson LC, Danis M, Garrett J.
What is wrong with end-of-life care? opinions of bereaved family members.
J Am Geriatr Soc.
1997;45:1339-1344.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
9361659>
22. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr22>
Levin JR, Wenger NS, Ouslander JG, et al.
Life-sustaining treatment decisions for nursing home residents: who
discusses, who decides and what is decided?
J Am Geriatr Soc.
1999;47:82-87.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
9920234>
23. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr23>
Goold SD, Arnold RM, Siminoff LA.
Discussions about limiting treatment in a geriatric clinic.
J Am Geriatr Soc.
1993;41:277-281.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
8440851>
24. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr24>
Alemayehu E, Molloy DW, Guyatt GH, et al.
Variability in physicians' decisions on caring for chronically ill elderly
patients: an international study.
CMAJ.
1991;144:1133-1138.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
2018965>
25. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr25>
Molloy DW, Guyatt GH, Alemayehu E, et al.
Factors affecting physicians' decisions on caring for an incompetent elderly
patient: an international study.
CMAJ.
1991;145:947-952.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
1913428>
26. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr26>
British Medical Association.
Withholding or Withdrawing Life-Prolonging Medical Treatment: Guidance for
Decision-making.
London, England: BMJ Books; 1999.
27. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr27>
van der Steen JT, Graas T, Ooms ME, van der Wal G, Ribbe MW.
When should physicians forgo curative treatment of pneumonia in patients
with dementia? using a guideline for decision-making.
West J Med.
2000;173:274-277.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
11018000>
28. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr28>
Hoek JF, Penninx BW, Ligthart GJ, Ribbe MW.
Health care for older persons, a country profile: the Netherlands.
J Am Geriatr Soc.
2000;48:214-217.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
10682953>
29. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr29>
Frijters DH, Mor V, DuPaquier J-N, Berg K, Carpenter GI, Ribbe MW.
Transitions across various continuing care settings.
Age Ageing.
1997;26(suppl 2):73-76.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
9464559>
30. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr30>
Institute for Health Care Information (SIG).
SIG Nursing Home Information System Annual Report Nursing Homes 1996 [in
Dutch].
Utrecht, the Netherlands: SIG; 1997.
31. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr31>
Ribbe MW.
Care for the elderly: the role of the nursing home in the Dutch health care
system.
Int Psychogeriatr.
1993;5:213-222.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
8292774>
32. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr32>
Hurley AC, Volicer BJ, Hanrahan PA, Houde S, Volicer L.
Assessment of discomfort in advanced Alzheimer patients.
Res Nurs Health.
1992;15:369-377.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
1529121>
33. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr33>
Hurley AC, Volicer B, Mahoney MA, Volicer L.
Palliative fever management in Alzheimer patients: quality plus fiscal
responsibility.
ANS Adv Nurs Sci.
1993;16:21-32.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
7508704>
34. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr34>
Volicer L, Collard A, Hurley A, Bishop C, Kern D, Karon S.
Impact of special care unit for patients with advanced Alzheimer's disease
on patients' discomfort and costs.
J Am Geriatr Soc.
1994;42:597-603.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
7515405>
35. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr35>
Mahoney EK, Hurley AC, Volicer L, et al.
Development and testing of the Resistiveness to Care Scale.
Res Nurs Health.
1999;22:27-38.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
9928961>
36. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr36>
Hoogendoorn LI, van de Kamp S, Sheer Mahomed CA, Adèr HJ, Ooms ME, van der
Steen JT.
The role of the observer in the reliability of the in Dutch translated
version of the Discomfort Scale–Dementia of Alzheimer Type (DS-DAT) [in
Dutch].
Tijdschr Gerontol Geriatr.
2001;32:117-121.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
11455871>
37. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr37>
Volicer L, Hurley AC, Lathi DC, Kowall NW.
Measurement of severity in advanced Alzheimer's disease.
J Gerontol.
1994;49:M223-M226.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
8056941>
38. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr38>
Bellelli G, Frisoni GB, Bianchetti A, Trabucchi M.
The Bedford Alzheimer Nursing Severity Scale for the severely demented:
validation study.
Alzheimer Dis Assoc Disord.
1997;11:71-77.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
9194953>
39. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr39>
Charlson ME, Sax FL, MacKenzie CR, Fields SD, Braham RL, Douglas RG Jr.
Assessing illness severity: does clinical judgment work?
J Chronic Dis.
1986;39:439-452.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
3086355>
40. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr40>
Snijders TAB, Bosker RJ.
Multilevel Analysis: An Introduction to Basic and Advanced Multilevel
Modeling.
London, England: Sage Publishers; 1999.
41. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr41>
Hox JJ.
Applied Multilevel Analysis.
Amsterdam, the Netherlands: TT-Publikaties; 1995.
42. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr42>
Moreno R, Apolone G, Miranda DR.
Evaluation of the uniformity of fit of general outcome prediction models.
Intensive Care Med.
1998;24:40-47.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
9503221>
43. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr43>
Hosmer DW, Lemeshow S.
Applied Logistic Regression.
New York, NY: John Wiley & Sons Inc; 1989.
44. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr44>
Hanley JA, McNeil BJ.
The meaning and use of the area under a receiver operating characteristic
(ROC) curve.
Radiology.
1982;143:29-36.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
7063747>
45. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr45>
Goldstein H, Rasbash J, Plewis I, et al.
A User's Guide to MLwiN Version 1.0.
London, England: Multilevel Models Project, Institute of Education,
University of London; 1998.
46. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr46>
Folstein MF, Folstein SE, McHugh PR.
Mini-mental state: a practical method for grading the cognitive state of
patients for the clinician.
J Psychiatr Res.
1975;12:189-198.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
1202204>
47. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr47>
Fabiszewski KJ, Volicer B, Volicer L.
Effect of antibiotic treatment on outcome of fevers in institutionalized
Alzheimer patients.
JAMA.
1990;263:3168-3172.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
1693407>
48. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr48>
Dobson ME, Ruben FL.
How to sort through the differential and institute therapy: the special
challenge of pneumonia in the elderly.
J Respir Dis.
1993;14:1145-1167.
49. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr49>
Osler W.
The Principles and Practice of Medicine Designed for the Use of
Practitioners and Students of Medicine.
3rd ed. London, England: Young J Pentland; 1898:109.
50. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr50>
Volicer BJ, Hurley A, Fabiszewski KJ, Montgomery P, Volicer L.
Predicting short-term survival for patients with advanced Alzheimer's
disease.
J Am Geriatr Soc.
1993;41:535-540.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
8486888>
51. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr51>
Mott PD, Barker WH.
Treatment decisions for infections occurring in nursing home residents.
J Am Geriatr Soc.
1988;36:820-824.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
3411066>
52. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr52>
Janknegt R, Wijnands WJ, Stobberingh EE.
Antibiotic policies in Dutch hospitals for the treatment of pneumonia.
J Antimicrob Chemother.
1994;34:431-442.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
7829419>
53. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr53>
Goettsch WG, Goossens H, de Neeling AJ, Sprenger MJW.
Infections and bacterial resistance in the community [in Dutch].
Ned Tijdschr Geneeskd.
1999;143:1296-1299.
MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
10416482>
54. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr54>
Morrison RS, Siu AL.
Mortality from pneumonia and hip fractures in patients with advanced
dementia.
JAMA.
2000;284:2447-2448.
FULL TEXT <http://jama.ama-assn.org/issues/v284n19/ffull/jlt1115-1.html>   |
PDF <http://jama.ama-assn.org/issues/v284n19/fpdf/jlt1115.pdf>   |   MEDLINE
<http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=
11074771>
55. <http://archinte.ama-assn.org/issues/v162n15/rfull/#rr55>
van der Steen JT, Ooms ME, van der Wal G, Ribbe MW.
Pneumonia: the demented patient's best friend? discomfort following starting
or withholding antibiotic treatment.
J Am Geriatr Soc.
In press.


Edward E. Rylander, M.D.
Diplomat American Board of Family Practice.
Diplomat American Board of Palliative Medicine.